Targeting peroxisome proliferator‐activated receptor γ proteasomal degradation by magnolol is a potential avenue for adipogenesis‐mediated metabolic homeostasis
Abstract
Objective: Adipogenesis has been recognized as an attractive avenue for maintaining systemic homeostasis, with peroxisome proliferator‐activated receptor γ (PPARγ) showing predominant roles in this process. This study aims to identify promising drug candidates by targeting PPARγ for adipogenesis‐based metabolic homeostasis and to clarify the detailed mechanisms.Methods: Molecular events contributing to adipogenesis were screened, which identified PPARγ as having the predominant role. Promising agents of adipogenesis agonism were screened using a PPARγ‐based luciferase reporter assay. The functional capacity and molecular mechanisms of magnolol were intensively examined using 3T3‐L1 preadipocytes and dietary models.Results: This study found that F‐box only protein 9 (FBXO9)‐mediated lysine 11 (K11)‐linked ubiquitination and proteasomal degradation of PPARγ are critically required during adipogenesis and systemic homeostasis. Notably, magnolol was identified as a potent adipogenesis activator by stabilizing PPARγ. The pharmacological mechanisms investigations clarified that magnolol directly binds to PPARγ and markedly interrupts its interaction with FBXO9, leading to a decline in K11‐linked ubiquitination and proteasomal degradation of PPARγ. Clinically important, magnolol treatment significantly facilitates adipogenesis in vitro and in vivo.Conclusions: The downregulation of K11‐linked ubiquitination of PPARγ caused by FBOX9 is essentially required for adipogenesis, while targeting PPARγ‐FBXO9 interaction provides a new avenue for the therapy of adipogenesis‐related metabolic disorder.Keywords
Funding Information
- National Natural Science Foundation of China (81770053, 81970011, 81970070, 81970364, 82170595)
This publication has 42 references indexed in Scilit:
- Adipose tissue browning and metabolic healthNature Reviews Endocrinology, 2013
- Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed miceMolecular Nutrition & Food Research, 2013
- Adipogenesis: From Stem Cell to AdipocyteAnnual Review of Biochemistry, 2012
- The Ubiquitin Ligase Siah2 Regulates PPARγ Activity in AdipocytesEndocrinology, 2012
- Molecular Determinants of Magnolol Targeting Both RXRα and PPARγPLOS ONE, 2011
- Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylationNature, 2011
- Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cellsLife Sciences, 2009
- Transcriptional coregulators in the control of energy homeostasisTrends in Cell Biology, 2007
- PPAR and human metabolic diseaseJournal of Clinical Investigation, 2006
- PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In VitroMolecular Cell, 1999